Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptevo Therapeutics

4.95
+0.17003.56%
Post-market: 5.000.0500+1.01%19:49 EDT
Volume:59.87K
Turnover:296.89K
Market Cap:3.35M
PE:0.00
High:5.10
Open:4.80
Low:4.80
Close:4.78
Loading ...
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 28, 2025

Major Issues Report

Form 8-K - Current report
Apr 22, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Apr 01, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 25, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 25, 2025

Correspondence

Form CORRESP - Correspondence
Feb 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Correspondence

Form CORRESP - Correspondence